Medical/Pharmaceuticals
Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023
CHANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ: ZJYL), aCayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results fo...
2023-08-24 04:15
2935
Optum Applauded by Frost & Sullivan for Advancing the Use of Real-World Evidence by Life Sciences Companies and for Its Market-leading Position
With a legacy of industry leadership, Optum offers a compelling value proposition and innovative solutions that effectively address market gaps, underpinning its sustained success. SAN ANTONIO, Aug. 23, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the landscape for real-world evidence...
2023-08-23 22:00
1787
Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit
Dr. Denlinger is currently NCCN's Chief Scientific Officer and previously served as Chair and Member of multiple NCCN Guidelines Panels—in charge of maintaining gold-standard evidence-based expert consensus cancer treatment recommendations. PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- To...
2023-08-23 20:06
1615
Innovent Announces 2023 Interim Results and Business Updates
Remarkable achievements with accelerated growth and improved efficiency to underpin sustainable growth ROCKVILLE, M.D. and SUZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and comme...
2023-08-23 19:38
4603
Dizal's Sunvozertinib Approved by China NMPA with Potential for Best-in-class Therapy in NSCLC with EGFR Exon20ins Mutations
* Sunvozertinib, a selective EGFR TKI targeting a wide spectrum of EGFR mutations, is the first Chinese Innovative drug approved for NSCLC Patients with EGFR Exon20ins * Approval based on the results of primary endpoint from WU-KONG6 study, which demonstrated a superior confirmed objective re...
2023-08-23 19:21
951
Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US
Two implants were successfully conducted as part of the FDA approved Early Feasibility Study inthe United States YOKNEAM, Israel, Aug. 23, 2023 /PRNewswire/ -- The heart teams at the Piedmont Heart Institute inAtlanta, Georgia, USA and the University of Virginia Health System inCharlottesville, ...
2023-08-23 18:07
1175
Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System
SUNNYVALE, Calif., Aug. 23, 2023 /PRNewswire/ -- Aquedeon Medical, Inc., a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to announce a significant milestone following receipt of FDA Investigational Device Exemption (IDE) approval to c...
2023-08-23 18:00
954
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company
MELBOURNE, Australia, Aug. 23, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended30 June 2023. All figures are in AUD$ unless otherwise stated.[1] Financial highlights * Total Group revenue $220.8M ...
2023-08-23 17:40
1400
USANA Philippines Celebrates Legacy of Wellness Empowerment With Enterprise Asia Linchpin of Asia Awards 2023
SINGAPORE, Aug. 22, 2023 /PRNewswire/ -- Founded in 1992 by microbiologist and immunologist Dr. Myron Wentz, USANA Health Sciences is a U.S.-based international direct-selling company that researches, manufactures, and sells premium, science-based supplements, personal care, and healthy living...
2023-08-23 17:06
1652
Maypharm Launches the world first Adipose Stem Cell Exosome hair filler, HAIRNA Exosome Hair Fill
SEOUL, South Korea and NEW YORK, Aug. 23, 2023 /PRNewswire/ -- Maypharm
Launches the world first Adipose Stem Cell Exosome hair filler, HAIRNA Exosome
Hair Fill. HAIRNA Exosome Hair Fill is developed with Maypharm's exclusive
technology for scalp rejuvenation and hair growth.
2023-08-23 17:00
1501
Leading by Inspiration: KPJ Tawakkal KL Specialist Hospital Triumphs with Asia Pacific Enterprise Award for its Exceptional Brand
SINGAPORE, Aug. 23, 2023 /PRNewswire/ -- KPJ Tawakkal KL Specialist Hospital (KPJ TWKL), a renowned name in the healthcare industry, has achieved yet another milestone by being honored with the prestigious Inspirational Brand Award at the Asia Pacific Enterprise Awards 2023 Malaysia. This recogni...
2023-08-23 15:18
1726
ImmVira Appoints Howard L. Kaufman, M.D. as Consulting Medical Advisor
SHENZHEN, China, Aug. 22, 2023 /PRNewswire/ -- ImmVira announced to appoint Dr. Howard L. Kaufman as Consulting Medical Advisor. Dr. Kaufman's expertise in scientific research and clinical development, especially in the areas of oncolytic virus and immunotherapy, will greatly enhance ImmVira's re...
2023-08-23 10:51
1762
MGI Partners with NGeneBio to Advance Precision Medicine
SEOUL, South Korea, Aug. 23, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science and NGeneBio, a company specializing in next-generation sequencing-based diagnostic have signed a memorandum of understanding (MOU) to expand the commercial access...
2023-08-23 09:00
2366
Lynk Pharmaceuticals Announces Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Ankylosing Spondylitis
HANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (referred to as "Lynk Pharmaceuticals"), an innovative clinical stage company, announced positive topline data from a Phase II clinical trial of LNK01001 for the treatment of ankylosing spondylitis (AS). The study, led...
2023-08-23 08:00
3119
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results
First patient dosed in a PEG-IFN-α controlled BRII-835 + PEG-IFN-α combination Phase 2 study for HBV functional cure First of several studies to investigate the potential of BRII-179 in enriching patients with strong intrinsic anti-HBsAg responses for curative treatments to start before the end ...
2023-08-22 22:00
3379
Paradigm Therapeutics Acquires Late Stage "Breakthrough Therapy" Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)
'Topical Therapy for Treating the Wounds and Lesions on the Entire Skin Surface' MT PLEASANT, S.C., Aug. 22, 2023 /PRNewswire/ -- Paradigm Therapeutics Inc., a biopharmaceutical company, today announced the completion of the acquisition of the worldwide rights of SD-101, a topical whole-body trea...
2023-08-22 21:13
2210
Asieris Pharmaceuticals Unveils 2023 Semi-Annual Report, Demonstrating Initial Success of Specialty Pharma Strategy and Multi-Product Synergistic Commercialization
SHANGHAI, Aug. 22, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH) – a global innovative pharmaceutical company specializing in the discovery, development and commercialization of innovative drugs that treat genitourinary (GU) tumors and other related diseases – today release...
2023-08-22 20:58
2242
Sanyou Biopharmaceuticals and Sinorda Biomedicine signed Strategic Cooperation Agreement for Advancing Innovative Drug Research and Development
SHANGHAI, Aug. 22, 2023 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (referred to as "Sanyou" hereafter) and Sinorda Biomedicine (referred to as " Sinorda " hereafter) have officially signed a strategic cooperation agreement to advance the innovative bispecific antibody drug pro...
2023-08-22 20:00
1819
CARsgen Announced 2023 Interim Results
SHANGHAI, Aug. 22, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced its 2023 Interim Results. Business Highlights * Collaboration agr...
2023-08-22 19:30
3358
Ratchaphruek Hospital in Khon Kaen, Thailand Achieves GHA Accreditation with Excellence, Affirming Its World-Class Services for Medical Travelers
KHON KAEN, Thailand, Aug. 22, 2023 /PRNewswire/ -- Ratchaphruek Hospital in Khon Kaen province,Thailand, has achieved a significant milestone by being awarded Accreditation with Excellence for Medical Travel Services byGlobal Healthcare Accreditation (GHA). This accolade underscores Ratchaphruek ...
2023-08-22 18:00
1437
Week's Top Stories
Most Reposted
Agoda releases generative AI film to capture the joy of travel
[Picked up by 349 media titles]
2024-12-10 10:00
Mastercard Economics Institute: APAC growth expected to hold steady in 2025; global policy resets may see shift in gears
[Picked up by 313 media titles]
2024-12-10 09:00Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
[Picked up by 306 media titles]
2024-12-09 10:00
CCTV+: Yuhang Journey ǀ Follow Olivier to Explore Ancient Liangzhu and Savor Jingshan Tea
[Picked up by 283 media titles]
2024-12-08 20:076th HIIFF Closes with Golden Coconut Award Ceremony
[Picked up by 282 media titles]
2024-12-11 22:19
Most Read
TEDA Celebrates 40 Years of Pioneering Innovation, Inclusive Opening-up, and Synergistic development
2024-12-07 19:16
4024
